4142 — Adimmune Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapSucker Stock

Annual cashflow statement for Adimmune, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	1,197	14.3	156	-770	-336
Depreciation
Amortisation
Non-Cash Items	16.9	30.6	27.7	422	55.9
Unusual Items
Other Non-Cash Items
Changes in Working Capital	880	-751	-735	-769	733
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	2,322	-481	-292	-892	668
Capital Expenditures	-553	-845	-341	-379	-232
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	936	116	19.2	12.3	-78.7
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	383	-729	-322	-367	-311
Financing Cash Flow Items	166	-212	279	0	116
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	324	-223	823	859	-479
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	3,034	-1,435	205	-400	-113